Rishi Shah

Rishi Shah is currently the Head of Chemistry at Ubiquigent Ltd. Prior to this role, Rishi has held various positions at GSK, including Scientific Investigator, Senior Scientist, and Synthetic Medicinal Chemist. Rishi also worked as a Research Scientist at Kuecept Ltd. Rishi's educational background includes a Visiting Scientist degree from Imperial College London, a PhD in Medicinal Chemistry and Chemical Biology from the University of Strathclyde, an MSci in Pharmaceutical Chemistry from Queen Mary University of London, and a Postgraduate Certificate in Professional Development in Medicinal Chemistry from the University of Kent. Additionally, Rishi completed an internship at GSK focused on process chemistry to scale up the anti-cancer drug, Trametinib.